Modified cells prove safe in long-term HIV study

Most of the patients with HIV who received infusions of modified versions of their immune cells remain healthy as many as 11 years after treatment, according to a study published in the journal Science Translational Medicine. Samples taken from patients showed the modified cells were at stable levels, researchers said. The findings indicate that modified cells are safe and continue to work more than a decade after infusion, which could open the treatments to less serious conditions.

View Full Article in:

Gene Therapy Safe in Decade-Long HIV Study That May Widen Use - Bloomberg

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX